Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 16;22(5):45.
doi: 10.1007/s11912-020-00904-z.

Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement

Affiliations
Review

Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement

James M Snyder et al. Curr Oncol Rep. .

Abstract

Purpose of review: Real-world data (RWD) applications in healthcare that support learning health systems and pragmatic clinical trials are gaining momentum, largely due to legislation supporting real-world evidence (RWE) for drug approvals. Clinical notes are thought to be the cornerstone of RWD applications, particularly for conditions with limited effective treatments, extrapolation of treatments from other conditions, or heterogenous disease biology and clinical phenotypes.

Recent findings: Here, we discuss current issues in applying RWD captured at the point-of-care and provide a framework for clinicians to engage in RWD collection. To achieve clinically meaningful results, RWD must be reliably captured using consistent terminology in the description of our patients. RWD complements traditional clinical trials and research by informing the generalizability of results, generating new hypotheses, and creating a large data network for scientific discovery. Effective clinician engagement in the development of RWD applications is necessary for continued progress in the field.

Keywords: Big data; Bioinformatics real-world data; CDE; Common data elements; Electronic health record; Learning health systems; Neuro-oncology; Neuroinformatics; Point-of-care; Pragmatic clinical trials; Precision medicine; RWD; RWE; Real-world evidence.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Real-world evidence (RWE) is derived from real-world data (RWD) systematically obtained from a multitude of sources loosely defined as patient information obtained outside of traditional research settings. RWE can expand the impact of prospective interventional clinical trials through evidence generation of the patient experience in conditions most similar to everyday healthcare situations (i.e., patients with additional comorbidities treated in routine clinical environments). Pragmatic clinical trials are a study type aimed at showing impact of an intervention in broad patient populations with minimal deviation in standard practice and are thus well-suited to RWE-based analysis. Classical clinical trials, RWE, and pragmatic trials inform learning healthcare systems

References

    1. Shanafelt TD, Dyrbye LN, Sinsky C, Hasan O, Satele D, Sloan J, et al. Relationship between clerical burden and characteristics of the electronic environment with physician burnout and professional satisfaction. Mayo Clin Proc. 2016;91:836–48. - PubMed
    1. Commissioner O of the Real-World Evidence [Internet]. FDA. 2019. [cited 2019 Nov 26]. Available from: http://www.fda.gov/science-research/science-and-research-special-topics/....
    1. Torous J, Kiang MV, Lorme J, Onnela J-P. New tools for new research in psychiatry: a scalable and customizable platform to empower data driven smartphone research. JMIR Ment Health [Internet]. 2016. [cited 2018 Jun 23]:3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873624/. - PMC - PubMed
    1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291: 2720–6. - PubMed
    1. Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109–17. - PubMed

Publication types